Abstract
A humanized version of the apoptosis-inducing mouse anti-human Fas monoclonal antibody, HFE7A, is under further development for the treatment of autoimmune diseases such as rheumatoid arthritis. We have crystallized the antigen-binding fragment (Fab) of the humanized HFE7A. The crystals belong to the orthorhombic space group P2 1 2 1 2 1 with cell dimensions a = 54.4 Å, b = 82.7 Å, c = 104.9 Å and contain one Fab molecule in the asymmetric unit. X-ray diffraction data were collected to 2.8 Å resolution.
Keywords: fab fragment, humanized hfe7a, fas monoclonal antibody
Protein & Peptide Letters
Title: Crystallization and Preliminary X-Ray Studies of the Fab Fragment from a Humanized Version of the Mouse Anti-Human Fas Antibody Hfe7a
Volume: 9 Issue: 3
Author(s): Shuichiro Ito, Tomoko Takayama, Hiroyuki Hanzawa, Tohru Takahashi, Kenji Miyadai, Nobufusa Serizawa, Hideyuki Haruyama and Tadashi Hata
Affiliation:
Keywords: fab fragment, humanized hfe7a, fas monoclonal antibody
Abstract: A humanized version of the apoptosis-inducing mouse anti-human Fas monoclonal antibody, HFE7A, is under further development for the treatment of autoimmune diseases such as rheumatoid arthritis. We have crystallized the antigen-binding fragment (Fab) of the humanized HFE7A. The crystals belong to the orthorhombic space group P2 1 2 1 2 1 with cell dimensions a = 54.4 Å, b = 82.7 Å, c = 104.9 Å and contain one Fab molecule in the asymmetric unit. X-ray diffraction data were collected to 2.8 Å resolution.
Export Options
About this article
Cite this article as:
Ito Shuichiro, Takayama Tomoko, Hanzawa Hiroyuki, Takahashi Tohru, Miyadai Kenji, Serizawa Nobufusa, Haruyama Hideyuki and Hata Tadashi, Crystallization and Preliminary X-Ray Studies of the Fab Fragment from a Humanized Version of the Mouse Anti-Human Fas Antibody Hfe7a, Protein & Peptide Letters 2002; 9 (3) . https://dx.doi.org/10.2174/0929866023408715
DOI https://dx.doi.org/10.2174/0929866023408715 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of Apoptosis in Arthritis
Current Rheumatology Reviews Nucleic Acid Aptamers Based on the G-Quadruplex Structure: Therapeutic and Diagnostic Potential
Current Medicinal Chemistry Recent Developments in Drug Design of NO-donor Hybrid Compounds
Mini-Reviews in Medicinal Chemistry Meet Our Regional Editor:
Medicinal Chemistry Molecularly Guided Therapy of Neuroblastoma: A Review of Different Approaches
Current Pharmaceutical Design Quantitative Ultrasound in Diagnosis of Metabolic Bone Diseases
Current Medical Imaging Update on Clinical, Pathophysiological and Therapeutic Aspects in ANCAAssociated Vasculitides
Current Drug Discovery Technologies Pomegranate Use to Attenuate Bone Loss in Major Musculoskeletal Diseases: An Evidence-Based Review
Current Drug Targets A Review on Repurposed Drugs and Vaccine Trials for Combating SARS CoV-2
Current Drug Research Reviews Ideational Fluency in Patients with Rheumatoid Arthritis
Current Rheumatology Reviews The Heme Oxygenase System and Type-1 Diabetes
Current Pharmaceutical Design Psychological Factors Associated with Response to Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design Progress Towards the Identification of New Aggrecanase Inhibitors
Current Medicinal Chemistry Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders
Current Pharmaceutical Design Sporadic Porphyria in a Patient with Stage II Melanoma Treated with Interferon α
Current Drug Safety Accelerating Drug Discovery by Integrative Implementation of Laboratory Automation in the Work Flow
Current Medicinal Chemistry Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors
Current Topics in Medicinal Chemistry Preface
Current Pharmaceutical Design The Inflammatory Milieu of the Degenerate Disc: Is Mesenchymal Stem Cell-based Therapy for Intervertebral Disc Repair a Feasible Approach?
Current Stem Cell Research & Therapy Pathway to the Clinic: Inhibition of P38 MAP Kinase. A Review of Ten Chemotypes Selected for Development
Current Topics in Medicinal Chemistry